Non-hospital 340B covered entities have formed a group called 340B Grantees to fight on their own behalf on legislation, in courts, and perhaps in politics at the federal and state levels.
340B Grantees hasn’t formally announced itself yet and is
…
Category: Federal
It is time for Congress to make it crystal clear that contract pharmacies are integral to the 340B program, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell’s blog.
Federal courts have struck down federal
…
The American Hospital Association has asked U.S. Health and Human Services Secretary Xavier Becerra again to waive a requirement that it says is forcing hospitals out of the 340B program due to COVID-19-related changes in payer mix.
AHA President and
…
Drug manufacturer AstraZeneca and two health centers aligned with Ryan White Clinics for 340B Access (RWC-340B) briefed a 340B administrative dispute resolution (ADR) panel last week on whether a recent federal court ruling has implications for the health centers’ 340B
…
President Biden urged Congress in his State of the Union message Tuesday night to cap monthly cost sharing for insulin at $35 and let Medicare negotiate what it pays for prescription drugs.
Biden said cutting the cost of prescription drugs
…
Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”
Sens. Elizabeth Warren (Mass.) and Amy
…
The federal government indicated in a court filing last week that it will appeal the court’s decision striking down and vacating the government’s letter telling drug company AstraZeneca its conditions on 340B pricing when covered entities use contract pharmacy were
…
340B provider and drug industry stakeholders joined yesterday in congratulating U.S. Public Health Service Lt. Cmdr. Emeka Egwim on his selection as Director of the U.S. Office of Pharmacy Affairs, the federal agency that runs the 340B drug pricing program.
…
A Democratic push in Congress to cap insulin costs for patients is gaining momentum. It may be a sign that some in the party are giving up on trying to pass comprehensive drug pricing legislation and focusing now on trying
…